l carnitine and graves disease Adding L-Carnitine Selenium to Methimazole in Graves' Disease: A Prospective Randomized Trial on Thyroid Markers and Quality of Life Carnitine Deficiency in Chronic Kidney

The antibody-drug conjugate according to any one of embodiments 1-21 , for use as a medicament, preferably for use in the treatment of a tumor in a subject in need thereof, for example a solid tumor, more specifically selected from the group consisting of ovarian cancer, breast cancer, lung cancer, or mesothelioma

2 In support of its essential role in physiology, VitC acts as a cofactor for numerous enzymes, many of which are involved in crucial biochemical pathways

doi: 10.1074/jbc.M300714200 212 SoutschekJAkincABramlageBCharisseKConstienRDonoghueMet al

This review critically examines the anticancer properties of various NCs, including quercetin, curcumin, resveratrol, EGCG, berberine, ellagic acid, withaferin A, celastrol, and others, against OC

We therefore checked the protein expression of MAFbx and MuRF1 in the TNF--induced myotube atrophy model and the CT26 tumor-bearing mice to confirm the anti-catabolic effects of L-carnitine